2017
DOI: 10.7150/thno.19840
|View full text |Cite|
|
Sign up to set email alerts
|

In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell

Abstract: Inhibition of the interaction between p53 and MDM2/MDMX has attracted significant attention in anticancer therapy development. We designed a series of in-tether chiral center-induced helical stabilized peptides, among which MeR/PhR effectively reactivated p53. The activation of p53 inhibits cell proliferation and induces apoptosis in both the MCF-7 normal tumor cell line and the PA-1 pluripotent cancer cell line with only minimal cellular toxicity towards normal cells or cancer cell lines with p53 mutations. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
18
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
2
1

Relationship

3
6

Authors

Journals

citations
Cited by 24 publications
(18 citation statements)
references
References 41 publications
0
18
0
Order By: Relevance
“…It plays a very important role in the regulation of cell cycle checkpoints caused by DNA damage and participates in maintaining genome stability. 48-50 MDMX, as an inhibitor of p53, could cause the ubiquitination and degradation of p53 [51][52][53]. CHK2 could inhibit the activity of MDMX and then rescue the inhibition of p53 53,54.…”
mentioning
confidence: 99%
“…It plays a very important role in the regulation of cell cycle checkpoints caused by DNA damage and participates in maintaining genome stability. 48-50 MDMX, as an inhibitor of p53, could cause the ubiquitination and degradation of p53 [51][52][53]. CHK2 could inhibit the activity of MDMX and then rescue the inhibition of p53 53,54.…”
mentioning
confidence: 99%
“…After proving CIH concept could be successfully translated, we applied this method to construct longer peptides 3S / 3R and FITC‐3S / FITC‐3R (Figure A) to target MDM2, which is a major negative regulator of the tumor suppressor p53 protein and has been reported as a suitable target for constrained peptides . Their thioether tethered counterparts 4S / 4R and FITC‐4S / FITC‐4R were also prepared as control peptides (Figure A).…”
Section: Results and Disscussionmentioning
confidence: 99%
“…Is the inefficacy due to increasing percentage of CSC population in Cal-27, PA-1, and Cal-27 CisR cells? [22,50]. Dysplasia cells (DysMSCTR16) were not affected by ascorbic acid or the amla and ginger extracts, in regard to cell proliferation.…”
Section: Discussionmentioning
confidence: 97%